Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Morgan

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Urology|April 1, 1989
Cytotoxicity of high energy shock waves: methodologic considerationsV P Laudone, T R Morgan, R F Huryk, et al.
The Journal of Infectious Diseases|November 1, 1986
Clustering of delta hepatitis in a family from LebanonT L Fong, K M DeCock, S Govindarajan, et al.
The American Journal of Gastroenterology|November 1, 1993
Expression of the beta 1 chain (CD29) of integrins and CD45 in alcoholic liver disease. The VA Cooperative Study Group No. 275A Chedid, C L Mendenhall, T E Moritz, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shuntG T Everson, M A Martucci, M L Shiffman, et al.
Cancer|October 1, 1987
Synchronous neoplasms in patients with diminutive colorectal adenomasM R Tripp, T R Morgan, R E Sampliner, et al.
Current Eye Research|January 1, 1981
Water soluble marihuana-derived material: pharmacological actions in rabbit and primateK Green, C M Symonds, R D Elijah, et al.
Journal of Hepatology|April 29, 1998
A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis CT L Fong, S H Han, N C Tsai, et al.
Applied Optics|August 2, 2008
Lidar system model for use with path obscurants and experimental validationJ W Giles, I N Bankman, R M Sova, et al.
Journal of Viral Hepatitis|November 13, 2001
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapyJ G McHutchison, J A Shad, S C Gordon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 16, 2001
Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumorQ Dan, R Sanchez, C Delgado, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Urology|April 1, 1989
Cytotoxicity of high energy shock waves: methodologic considerationsV P Laudone, T R Morgan, R F Huryk, et al.
The Journal of Infectious Diseases|November 1, 1986
Clustering of delta hepatitis in a family from LebanonT L Fong, K M DeCock, S Govindarajan, et al.
The American Journal of Gastroenterology|November 1, 1993
Expression of the beta 1 chain (CD29) of integrins and CD45 in alcoholic liver disease. The VA Cooperative Study Group No. 275A Chedid, C L Mendenhall, T E Moritz, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
Portal-systemic shunting in patients with fibrosis or cirrhosis due to chronic hepatitis C: the minimal model for measuring cholate clearances and shuntG T Everson, M A Martucci, M L Shiffman, et al.
Cancer|October 1, 1987
Synchronous neoplasms in patients with diminutive colorectal adenomasM R Tripp, T R Morgan, R E Sampliner, et al.
Current Eye Research|January 1, 1981
Water soluble marihuana-derived material: pharmacological actions in rabbit and primateK Green, C M Symonds, R D Elijah, et al.
Journal of Hepatology|April 29, 1998
A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis CT L Fong, S H Han, N C Tsai, et al.
Applied Optics|August 2, 2008
Lidar system model for use with path obscurants and experimental validationJ W Giles, I N Bankman, R M Sova, et al.
Journal of Viral Hepatitis|November 13, 2001
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapyJ G McHutchison, J A Shad, S C Gordon, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 16, 2001
Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumorQ Dan, R Sanchez, C Delgado, et al.
Pageof 5